Find News

Filter articles

Applied Filters

Showing 91 to 100 of 861 results

Teva infringed UCB patent, rules Fed Circuit


The US Court of Appeals for the Federal Circuit yesterday, June 24, upheld a lower court’s finding that UCB’s patent is infringed by a planned generic version of Neupro, a patch to treat Parkinson’s disease.

Fed Circuit sides with Merck in antifungal treatment dispute


A US court has upheld a decision that eight claims of one of Mayne Pharma’s patents are unpatentable for obviousness over prior art after a validity challenge was brought by a subsidiary of Merck & Co.

Generic drugs cost 30x more in poor countries: report

India, US, Zimbabwe20-06-2019

Generic medicines can cost up to 30 times more in poor countries, according to a new study.

India to make barcoding mandatory on all drugs


India is to make barcoding mandatory on all medicines sold within the country after a recent report by the Office of the US Trade Representative (USTR) identified the country as the largest producer of counterfeit pharmaceuticals in the world.

German court deals blow to Sanofi over cholesterol drug


A German court has rejected a bid from French pharmaceutical company Sanofi to have a patent infringement case dismissed.

Tokyo court dismisses Genentech patent suit against Sandoz


A Japanese court has dismissed a patent infringement lawsuit brought by Roche subsidiary Genentech against Sandoz, a division of Novartis.

CMA accuses 4 pharma companies of anti-competitive conduct


Four pharmaceutical companies allegedly agreed not to compete for the supply of an anti-nausea tablet to the National Health Service, according to objections filed by the UK Competition and Markets Authority.

‘Considerable increase’ in pay-for-delay settlements: FTC report


The number of ‘pay-for-delay’ patent settlements reached in fiscal year 2016 represented a “considerable increase” from the previous year, according to a Federal Trade Commission report released yesterday, May 23, though there has been a considerable reduction in the most problematic settlements since 2013.

Eli Lilly releases generic insulin injection


Eli Lilly has released a generic insulin injection at half of the list price of its identical branded medicine to the US market.

City of Baltimore accuses Janssen of delaying generics


Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, is being sued for “unlawfully” delaying generic competition to Zytiga, its branded cancer medication.

Showing 91 to 100 of 861 results